Heart involvement in cystic fibrosis: A specific cystic fibrosis-related myocardial changes?

Respiratory Medicine

Volumn 118, Issue , 2016, Pages 31-38

  Labombarda, Fabien ^a   Saloux, Eric ^a   Brouard, Jacques ^a   Bergot, Emmanuel ^a   Milliez, Paul ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Cystic fibrosis; Heart

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

CARDIAC IMAGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CYSTIC FIBROSIS; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; HYPERCAPNIA; HYPOXEMIA; LUNG VASCULAR RESISTANCE; MYOCARDIAL DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RADIONUCLIDE VENTRICULOGRAPHY; REVIEW; RISK ASSESSMENT; SYSTOLIC DYSFUNCTION; CARDIAC MUSCLE; CARDIOMYOPATHY; COMPLICATION; DIAGNOSTIC IMAGING; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE; HYPOXIA; INFLAMMATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

CARDIOMYOPATHIES; CYSTIC FIBROSIS; ECHOCARDIOGRAPHY; HEART VENTRICLES; HUMANS; HYPOXIA; INFLAMMATION; MYOCARDIUM; PROGNOSIS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84978712534     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2016.07.011     Document Type: Review

References (60)

1. Davies, J.C., Alton, E.W., Bush, A., Cystic fibrosis. BMJ 335 (2007), 1255–1259.
2. Bright-Thomas, R.J., Webb, A.K., The heart in cystic fibrosis. J. R. Soc. Med. 41:95 Suppl (2002), 2–10.
3. Labombarda, F., Pellissier, A., Ellafi, M., et al. Myocardial strain assessment in cystic fibrosis. J. Am. Soc. Echocardiogr. 24 (2011), 1037–1045.
4. Ozcelik, N., Shell, R., Holtzlander, M., Cua, C., Decreased right ventricular function in healthy pediatric cystic fibrosis patients versus non-cystic fibrosis patients. Pediatr. Cardiol. 34 (2013), 159–164.
5. Sellers, Z.M., McGlocklin, L., Brasch, A., Strain rate echocardiography uncovers subclinical left ventricular dysfunction in cystic fibrosis. J. Cyst. Fibros. 14 (2015), 654–660.
6. Johnson, G.L., Kanga, J.F., Moffett, C.B., Noona, J.A., Changes in left ventricular diastolic filling patterns by Doppler echocardiography in cystic fibrosis. Chest 99 (1991), 646–650.
7. Gonzales, M.P., Suarez, L., Camarero, C., Escobar, H., Myocardial fibrosis in 2children with cystic fibrosis. An. Esp. Pediatr. 27 (1987), 382–384.
8. Berger, M., Inflammatory mediators in cystic fibrosis lung disease. Allergy Asthma Proc. 23 (2002), 19–25.
9. Sellers, Z.M., De Arcangelis, V., Xiang, Y., Best, P.M., Cardiomyocytes with disrupted CFTR function require CaMKII and Ca(2+)-activated Cl(-) channel activity to maintain contraction rate. J. Physiol. 588 (2010), 2417–2429.
10. Ryland, D., Reid, L., The pulmonary circulation in cystic fibrosis. Thorax 30 (1975), 285–292.
11. Torriani, R., Chassot, J., Stocker, F., Weber, J.W., Two children with cystic fibrosis and myocardial fibrosis. Monogr. Paediatr. 10 (1979), 155–157.
12. Wiebicke, W., Artlich, A., Gerling, I., Myocardial fibrosis: a rare complication in patients with cystic fibrosis. Eur. J. Pediatr. 152 (1993), 694–696.
13. Cheron, G., Paradis, K., Steru, D., Demay, G., Lenoir, G., Cardiac involvement in cystic fibrosis revealed by a ventricular arrhythmia. Acta Paediatr. Scand. 73 (1984), 697–700.
14. Zimmermann, A., Stocker, F., Johr, M., Torriani, R., Chassot, J., Weber, J.W., Cardiomyopathy in cystic fibrosis: lymphoedema of the heart with focal myo- cardial fibrosis. Helv. Paediatr. Acta 37 (1982), 183–192.
15. Nezelof, C., Bouvier, R., Dijoud, F., Multifocal myocardial necrosis: a distinctive cardiac lesion in cystic fibrosis, lipomatous pancreatic atrophy, and Keshan disease. Pediatr. Pathol. Mol. Med. 21 (2002), 343–352.
16. Zebrak, J., Skuza, B., Pogorzelski, A., et al. Partial CFTR genotyping and characterisation of cystic fibrosis patients with myocardial fibrosis and necrosis. Clin. Genet. 57 (2000), 56–60.
17. Stern, R.C., Borkat, G., Hirschfeld, S.S., et al. Heart failure in cystic fibrosis. Treatment and prognosis of cor pulmonale with failure of the right side of the heart. Am. J. Dis. Child. 134 (1980), 267–272.
18. Sellers, Z.M., Best, P.M., Investigation of left ventricular function in CFTR knockout mice uncovers cardiovascular disturbances independent of lung disease. Pediatr. Pulmonol., 33, 2010.
19. Duan, D.D., Ye, L., Novel cardioprotective function of CFTR chloride channels against myocardial hypertrophy and heart failure. Circulation, 124, 2011, A18267.
20. Baño-Rodrigo, A., Salcedo-Posadas, A., Villa-Asensi, J.R., Tamariz-Martel, A., Lopez-Neyra, A., Blanco-Iglesias, E., Right ventricular dysfunction in adolescents with mild cystic fibrosis. J. Cyst. Fibros. 11 (2012), 274–280.
21. Florea, V.G., Florea, N.D., Sharma, R., et al. Right ventricular dysfunction in adult severe cystic fibrosis. Chest 118:4 (2000 Oct), 1063–1068.
22. Chipps, B.E., Alderson, P.O., Roland, J.M., Yang, S., et al. Noninvasive evaluation of ventricular function in cystic fibrosis. J. Pediatr., 95, 1979, 379.
23. Matthay, R.A., Berger, H.J., Loke, J., et al. Right and left ventricular performance in ambulatory young adults with cystic fibrosis. Br. Heart J. 43 (1980), 474–480.
24. Rosenthal, A., Tucker, C.R., Williams, R.G., et al. Echocardiographic assessment of cor pulmonale in cystic fibrosis. Pediatr. Clin. North Am. 23 (1976), 327–343.
25. Vizza, C.D., Lynch, J.P., Ochoa, L.L., et al. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 113 (1998), 576–583.
26. Hoffmann, H., Vogt, L., Volkner, E., Quantitative two-dimensional echocardiography: study results in patients with cystic fibrosis. Kinderarztl Prax. 58 (1990), 523–530.
27. Panidis, I.P., Ren, J.F., Holsclaw, D.S., et al. Cardiac function in patients with cystic fibrosis: evaluation by two-dimensional and Doppler echocardiography. J. Am. Coll. Cardiol. 6 (1985), 701–706.
28. Ionescu, A.A., Ionescu, A.A., Payne, N., Obieta-Fresnedo, I., Fraser, A.G., ShaleDJ. Subclinical right ventricular dysfunction in cystic fibrosis. Astudy using tissue Doppler echocardiography. Am. J. Respir. Crit. CareMed 163 (2001), 1212–1218.
29. Giacchi, V., Rotolo, N., Amato, B., et al. Heart involvement in children and adults with cystic fibrosis: correlation with pulmonary indexes and inflammation markers. Heart Lung Circ. 24 (2015), 1002–1010.
30. Ambrosi, P., Chazalettes, J.P., Viard, L., et al. Left ventricular involvement in mucoviscidosis after 2 years of age. Arch. Pediatr. 50 (1993), 653–656.
31. Koelling, T.M., Dec, G.W., Ginns, L.C., Semigran, M.J., Left ventricular diastolic function in patients with advanced cystic fibrosis. Chest 123 (2003), 1488–1494.
32. De Wolf, D., Franken, P., Piepsz, A., Dab, I., Left ventricular perfusion deficit in patients with cystic fibrosis. Pediatr. Pulmonol. 25 (1998), 93–98.
33. Benson, L.N., Newth, C.J., DeSouza, M., et al. Radionuclide assessment of right and left ventricular function during bicycle exercise in young patients with cystic fibrosis. Am. Rev. Respir. Dis. 130 (1984), 987–992.
34. Mannarino, S., Radaeilli, P., Braga, M., et al. Right and left ventricular involvement in patients with cystic fibrosis and respiratory failure. Pediatr. Pulmonol., S20, 2000, 294.
35. Kucukosmanoglu, O., Ozbarlas, N., Gocmen, A., Ozcelik, U., Kiper, N., Bilgic, A., Noninvasive cardiac evaluation of young patient with cystic fibrosis. Turk J. Pediatr. 40 (1998), 571–578.
36. Coffey, M.J., FitzGerald, M.X., McNicholas, W.T., Comparison of oxygen saturation during sleep and exercise in patients with cystic fibrosis. Chest 100 (1991), 659–662.
37. Fraser, K.L., Tullis, D.E., Sasson, Z., et al. Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia. Chest 115 (1999), 1321–1328.
38. Tonelli, A.R., Fernandez-Bussy, S., Lodhi, S., et al. Prevalence of pulmonary hypertension in end-stage cystic fibrosis and correlation with survival. J. Heart Lung Transpl. 29 (2010), 865–872.
39. Berger, M., Inflammatory mediators in cystic fibrosis lung disease. Allergy Asthma Proc. 23 (2002), 19–25.
40. Mann, D.L., The effect of tumor necrosis factor-alpha on cardiac structure and function: a tale of two cytokines. J. Card. Fail 2:4 Suppl (1996), S165–S172.
41. Herrera-Garza, E.H., Stetson, S.J., Cubillos-Garzon, A., Vooletich, M.T., Farmer, J.A., Torre-Amione, G., Tumor necrosis factor-alpha: a mediator of disease progression in the failing human heart. Chest 115 (1999), 1170–1174.
42. Kelly, R.A., Smith, T.W., Cytokines and cardiac contractile function. Circulation, 95, 1997 778–8135.
43. Hull, J.H., Garrod, R., Ho, T.B., et al. Increased augmentation index in patients with cystic fibrosis. Eur. Respir. J. 34 (2009), 1322–1328.
44. Hull, J.H., Ansley, L., Bolton, C.E., et al. The effect of exercise on large artery haemodynamics in cystic fibrosis. J. Cyst. Fibros. 10 (2011), 121–127.
45. Bismuth, E., Laborde, K., Taupin, P., et al. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J. Pediatr. 152 (2008), 540–545.
46. Christie, J.D., Edwards, L.B., Aurora, P., et al. Registry of the international society for heart and lung transplantation: twenty-fifth official adult lung and heart/lung transplantation report. J. Heart Lung Transpl. 2008:27 (2008), 957–969.
47. Fang, Z.Y., Prins, J.B., Marwick, T.H., Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr. Rev. 25 (2004), 543–567.
48. Warth, J.D., Collier, M.L., Hart, P., et al. CFTR chloride channels in human and simian heart. Cardiovasc Res. 31 (1996), 615–624.
49. Nagel, G., Hwang, T.C., Nastiuk, K.L., Nairn, A.C., Gadsby, D.C., The protein kinase A-regulated cardiac Cl− channel resembles the cystic fibrosis transmembrane conductance regulator. Nature 360 (1992), 81–84.
50. Jiang, K., Jiao, S., Vitko, M., et al. The impact of cystic fibrosis transmembrane regulator disruption on cardiac function and stress response. J. Cyst. Fibros. 15 (2016), 34–42.
51. Simmonds, N.J., Cullinan, P., Hodson, M.E., Growing old with cystic fibrosis - the characteristics of long-term survivors of cystic fibrosis. Respir. Med. 103 (2009), 629–635.
52. D.M. Rodman, J.M. Polis, Heltshe, et al., Late diagnosis defines a unique population of long-term survivors of cystic fibrosis, Am. J. Respir. Care Med., 171 : 621–626.
53. Van Iterson, E.H., Karpen, S.R., Baker, S.E., Wheatley, C.M., Morgan, W.J., Snyder, E.M., Impaired cardiac and peripheral hemodynamic responses to inhaled β₂-agonist in cystic fibrosis. Respir. Res., 16, 2015, 103.
54. Nash, E.F., Coonar, A.S., Stephenson, A.L., et al. Cardiac dysfunction in adult CF patients with severe lung disease - a retrospective cohort study. Pediatr. Pulmonol., 2007, 399.
55. Perrault, H., Coughlan, M., Marcotte, J.E., Drblik, S.P., Lamarre, A., Comparison of cardiac output determinants in response to upright and supine exercise in patients with cystic fibrosis. Chest 101:1 (1992 Jan), 42–51.
56. Williams, S.G., Jackson, M., Cooke, G.A., et al. How do different indicators of cardiac pump function impact upon the long-term prognosis of patients with chronic heart failure?. Am. Heart J., 150, 2005, 983.
57. Mogelvang, R., Sogaard, P., Pedersen, S.A., et al. Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population. Circulation 119 (2009), 2679–2685.
58. Koyama, J., Falk, R.H., Prognostic significance of strain Doppler imaging in light-chain amyloidosis. J. Am. Coll. Cardiol. Img 3 (2010), 333–342.
59. Labombarda, F., Barigou, A., Legallois, D., Campbell, K., Bergot, E., Milliez, P., Saloux, E., Tricuspid systolic peak velocity is a prognostic factor in patients with cystic fibrosis. Int. J. Cardiol. 199 (2015), 435–436.
60. Selimovic, N., Andersson, B., Bech-Hanssen, O., Lomsky, M., Riise, G.C., Rundqvist, B., Right ventricular ejection fraction during exercise as a predictor of mortality in patients awaiting lung transplantation: a cohort study. BMJ Open(4), 2013, 3.